Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Enzyme alerts cell's powerful army to repair DNA damage

Enzyme alerts cell's powerful army to repair DNA damage

September 06, 2007

New view of how damage is detected aids understanding of cancer, aging and neurological diseases

ANN ARBOR, Mich. - Scientists know that inside each cell, a little engine called RNA polymerase II does one essential job: It copies instructions from genes in the nucleus that get carried to production units in the rest of the cell to support our daily needs. Now researchers at the University of Michigan Medical School have shown that RNA polymerase II also constantly scans the cell's DNA for damage. When certain types of damage in DNA halt the action of RNA polymerase II, a stress signal is generated that alerts a key tumor-suppressor protein called p53.




The activities of p53, a master protein that responds to DNA damage by marshaling hundreds of genes to repair or eliminate damaged cells, have been the subject of thousands of studies. Mutations in the p53 gene occur in more than half of all cancers.

"We have come up with a new paradigm for how cells protect themselves against cancer-producing DNA lesions," says Mats Ljungman, Ph.D., a U-M researcher and lead author of a recent study in the Proceedings of the National Academy of Sciences.

"Much is known already about p53, but this adds a significant piece of knowledge about how it is activated," Ljungman adds. He is an associate professor in the Department of Radiation Oncology in the Division of Radiation and Cancer Biology at the U-M Comprehensive Cancer Center and associate professor of Environmental Health Sciences at the U-M School of Public Health.

A commentary in the journal praised the U-M study and urged more attention to RNA polymerases as major sensors "for all DNA damage response reactions."

Ljungman says the findings have implications for the study of cancer, aging and neurological diseases. Figuring out precisely how cells detect and repair damage is crucial in understanding what goes wrong in cancer, in which harmful mutations can elude the body's ability to control cell division.

Finding and repairing DNA lesions is a non-stop job for cells.

As many as 20,000 lesions occur daily in a cell's DNA, Ljungman says. Many stresses result from oxidation and other internal cell processes. In addition, our DNA is also challenged by sunlight, radiation and reactive chemicals found in food.

"So much damage happens all the time," Ljungman says. "That puts pressure on cells to efficiently scan the DNA and do something about it. That's what we think the transcription machinery is doing."

RNA polymerase II is the main enzyme involved in transcription, the process of reading the genetic code. The U-M team did a series of experiments to find out what happens when transcription is blocked. They found that using transcription-blocking agents such as ultraviolet light resulted in activation of the p53 stress response, independent of other cell processes.

When they micro-injected an anti-RNA polymerase agent into human cell nuclei, they found that p53 proteins then accumulated in the cell nucleus - one aspect of the stress response - even when no DNA damage occurred. Ljungman and his colleagues also discovered what happens when RNA polymerase II gets stuck on a kink or other lesion in the DNA. It sends a signal via two proteins that activate p53.

"These two proteins are saying, 'Transcription has stopped,'" says Ljungman. These early triggers act like the citizen who smells smoke and sounds a fire alarm, alerting the fire department. Then p53, like a team of fire fighters, arrives and evaluates what to do. To reduce the chance of harmful mutations that may result from DNA damage, p53 may kill cells or stop them temporarily from dividing, so that there is time for DNA repair.

Learning more about the processes involved in transcription could pay off in improved treatments in years to come. Cisplatin, a drug used to treat testicular and ovarian cancer, acts by stopping transcription and causing cells to die. Some other chemotherapy drugs block transcription too. But these types of drugs also damage a cancer patient's DNA in normal tissues, sometimes leading to other cancers later.

The study's findings eventually could lead to better drugs that might target transcription directly without those ill effects, Ljungman believes.

University of Michigan Health System



Related Polymerase Current Events and Polymerase News Articles Polymerase Current Events and Polymerase News RSS Polymerase Current Events and Polymerase News RSS
Plant polymerases IV and V are special forms of Polymerase II
It's a little like finding out that Superman is actually Clark Kent. A team of biologists at Washington University in St. Louis has discovered that two vital cellular components, nuclear RNA Polymerases IV and V (Pol IV and V), found only in plants, are actually specialized forms of RNA Polymerase II, an essential enzyme of all eukaryotic organisms, including humans.

Evolution in action: Our antibodies take 'evolutionary leaps' to fight microbes
With cold and flu season in full swing, the fact that viruses and bacteria rapidly evolve is apparent with every sneeze, sniffle, and cough. A new report in the January 2009 issue of The FASEB Journal, explains for the first time how humans keep up with microbes by rearranging the genes that make antibodies to foreign invaders. This research fills a significant gap in our understanding of how the immune system helps us survive.

Uncultured bacteria found in amniotic fluids of women who experience preterm births
Researchers from Case Western Reserve University and Yale University have made a significant advancement in understanding the cause behind why some pregnant women suffer from inflammations in the inner womb without any signs of an infection.

Scientists isolate genes that made 1918 flu lethal
By mixing and matching a contemporary flu virus with the "Spanish flu" - a virus that killed between 20 and 50 million people 90 years ago in history's most devastating outbreak of infectious disease - researchers have identified a set of three genes that helped underpin the extraordinary virulence of the 1918 virus.

CSHL scientists discover new way in which ubiquitin modifies transcriptional machinery to regulate gene activity
During gene transcription - the process inside the nucleus of cells by which DNA, the genetic material, is copied into RNA - a large, ever-changing multiprotein complex is enlisted to assist the DNA-copying enzyme in its challenging job.

Properties of Unusual Virus Revealed in Researchers
A team of researchers from Penn State University and the University of Chicago has uncovered clues that may explain how and why a particular virus, called N4, injects an unusual substance -- an RNA polymerase protein -- into an E. coli bacterial cell. The results, which are published in the current issue of the journal Molecular Cell, contribute to improved understanding of the infection strategies used by viruses that attack bacterial cells.

Interferon as long-term treatment for hepatitis C not effective, report HALT-C researchers
Use of the drug interferon as a long-term maintenance strategy to slow the progression of liver disease associated with the hepatitis C virus is ineffective, UT Southwestern Medical Center researchers and their colleagues from nine other institutions have found in a multicenter study.

Model unravels rules that govern how genes are switched on and off
For years, scientists have struggled to decipher the genetic instruction book that details where and when the 20,000 genes in a human cell will be turned on or off. Different genes operate in each cell type at different times, and this careful orchestration is what ultimately distinguishes a brain cell from a liver or skin cell.

Researchers solve piece of large-scale gene silencing mystery
A team led by Craig Pikaard, Ph.D., Washington University in St. Louis professor of biology in Arts & Sciences, has made a breakthrough in understanding the phenomenon of nucleolar dominance, the silencing of an entire parental set of ribosomal RNA genes in a hybrid plant or animal.

New gene silencing pathway found in plants
Biologists at Washington University in St. Louis have made major headway in explaining a mechanism by which plant cells silence potentially harmful genes.
More Polymerase Current Events and Polymerase News Articles


The Polymerase Chain Reaction

This is the first comprehensive handbook on polymerase chain reaction (PCR). Edited by the inventor of PCR and the 1993 Nobel Prize winner in Chemistry, Kary Mullis, and two prominent experts in the field. It provides the most up-to-date methodological protocols from the world's leading laboratories, as well as exciting new techniques and enhanced applications not yet available in book form....

Functional Studies in Yeast of Cyclin C and Rna Polymerase II Mediator Complex (Comprehensive Summaries of Uppsala Dissertations, 895)
by Darius Balciunas



Methods in Enzymology, Volume 371: RNA Polymerase and Associated Factors, Part D

RNA polymerase is molecule important to gene transcription. Along with associated factors, RNA polymerase is part of the process in which RNA is transcribed to produce a protein.* Models and methods for studying polymerase translocation* Assay for movements of RNA polymerase along DNA* Engineering of elongation complexes of bacterial and yeast RNA...

DNA fingerprinting in the twilight zone. (use of DNA polymerases to identify criminal suspects): An article from: The Hastings Center Report
by George J. Annas

This digital document is an article from The Hastings Center Report, published by Hastings Center on March 1, 1990. The length of the article is 2720 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation...



Viral Polymerases & Related Proteins (Methods in Enzymology)

The critically acclaimed laboratory standard for more than forty years, Methods in Enzymology is one of the most highly respected publications in the field of biochemistry. Since 1955, each volume has been eagerly awaited, frequently consulted, and praised by researchers and reviewers alike. More than 270 volumes have been published (all of them still in print) and much of the material is...

Diagnosis of Human Viruses by Polymerase Chain Reaction Technology
by Yechiel Becker

Hebrew University of Jerusalem, Israel. Frontiers of Virology, Volume 1. First of a new series presenting research discoveries which will help curb virus diseases. 92 International contributors, including 30...

Market profile: PCR for security applications.(polymerase chain reaction): An article from: Instrument Business Outlook
by Gale Reference Team

This digital document is an article from Instrument Business Outlook, published by Thomson Gale on February 28, 2007. The length of the article is 478 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation...



The 2007-2012 World Outlook for Polymerase Chain Reaction (PCR) Machines
by Philip M. Parker

This study covers the world outlook for polymerase chain reaction (PCR) machines across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to...

Functional Significance of Multiple Poly(A) Polymerases (Pap (Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine, 1140)
by Helena Nordvarg

Real-time polymerase chain reaction to diagnose lymphogranuloma venereum.(LETTERS): An article from: Emerging Infectious Diseases
by Servaas A. Morre, Joke Spaargaren, Johannes S.A. Fennema, Henry J.C. de Vries, Roel A. Coutinho, A. Salvador Pena

This digital document is an article from Emerging Infectious Diseases, published by U.S. National Center for Infectious Diseases on August 1, 2005. The length of the article is 1305 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any...

© 2009 BrightSurf.com